Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines - Related Studies

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

This study has been completed.

Study NCT00240292. Last updated on October 16, 2005. Information provided by AstraZeneca

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Heart Failure, Congestive

2	Additional conditions recognized in this trial
		Heart Failure

3	More general conditions related to this trial
		Cardiovascular Diseases
		Heart Diseases

4	Interventions listed in this trial
		Rosuvastatin

5	More general drug interventions related to this trial
		Anticholesteremic Agents
		Antilipemic Agents
		Antimetabolites
		Enzyme Inhibitors
		Hydroxymethylglutaryl-CoA Reductase Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		AstraZeneca